We are live on ! Find out more

PDLI

PDL BioPharma, Inc.

PDLI

Delisted

PDLI was delisted on the 30th of December, 2020.

186 hedge funds and large institutions have $466M invested in PDL BioPharma, Inc. in 2017 Q3 according to their latest regulatory filings, with 31 funds opening new positions, 63 increasing their positions, 44 reducing their positions, and 13 closing their positions.

New

Increased

Maintained

Reduced

Closed

138% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 13

45% more capital invested

Capital invested by funds: $321M → $466M (+$145M)

43% more repeat investments, than reductions

Existing positions increased: 63 | Existing positions reduced: 44

9% more funds holding

Funds holding: 171 → 186 (+15)

37% less call options, than puts

Call options by funds: $450K | Put options by funds: $717K

Holders

186

Holders Change

+15

Holders Change %

+8.77%

% of All Funds

4.64%

Holding in Top 10

–

Holding in Top 10 Change

–

Holding in Top 10 Change %

–

% of All Funds

–

New

Increased

Reduced

Closed

Calls

$450K

Puts

$717K

Net Calls

-$267K

Net Calls Change

-$555K

Top Buyers

1	Millennium Management New York	+$8.55M
2	Morgan Stanley New York	+$6.49M
3	State Street Boston, Massachusetts	+$5.81M
4	Mackenzie Financial Toronto Ontario, Ontario, Canada	+$3.96M
5	Dimensional Fund Advisors Austin, Texas	+$3.56M

Top Sellers

1	Citadel Advisors Miami, Florida	-$9.56M
2	Bank of America Charlotte, North Carolina	-$4.6M
3	Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada	-$3.61M
4	BlackRock New York	-$2.18M
5	Deutsche Bank Frankfurt Am Main Ge, Germany	-$2M

#	Name	Holding	Trade Value	Shares Change	Change in Stake
26	26 Norges Bank Oslo, Norway	$4.3M	-$997K	-358,416	-22%
27	27 Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden	$4.27M	+$246K	+88,400	+8%
28	28 Prudential Financial Newark, New Jersey	$4.24M	+$1.08M	+387,160	+45%
29	29 Two Sigma Investments New York	$3.97M	+$1.08M	+389,183	+50%
30	SCP 30 Seizert Capital Partners Birmingham, Michigan	$3.9M	-$312K	-112,073	-9%
31	BIP 31 Brandes Investment Partners La Jolla, California	$3.77M	+$14.9K	+5,369	+0.5%
32	32 California Public Employees Retirement System Sacramento, California	$3.68M	+$328K	+117,993	+12%
33	33 Robeco Institutional Asset Management Rotterdam, Netherlands	$3.46M	–	–	–
34	34 Deutsche Bank Frankfurt Am Main Ge, Germany	$3.42M	-$2M	-718,631	-42%
35	35 Allianz Asset Management Munich, Germany	$3.19M	+$408K	+146,817	+18%
36	36 Two Sigma Advisers New York	$3.19M	+$246K	+88,538	+10%
37	NI 37 Numeric Investors Boston, Massachusetts	$3.02M	-$1M	-361,200	-29%
38	38 DZ Bank Frankfurt Am Main, Germany	$2.92M	+$857K	+308,045	+56%
39	39 UBS Group Zurich, Switzerland	$2.82M	+$308K	+110,683	+15%
40	40 Nomura Holdings Tokyo, Japan	$2.7M	+$57.6K	+20,721	+3%
41	41 JP Morgan Chase New York	$2.54M	-$1.33M	-477,042	-39%
42	GCP 42 GSA Capital Partners London, United Kingdom	$2.38M	-$259K	-93,200	-12%
43	TCIM 43 TIAA CREF Investment Management New York	$2.34M	+$689K	+247,720	+56%
44	OSAM 44 O'Shaughnessy Asset Management Stamford, Connecticut	$2.17M	+$1.75M	+629,597	+6,859%
45	SFM 45 Systematic Financial Management Teaneck, New Jersey	$1.69M	-$600K	-215,810	-30%
46	AA 46 ALPS Advisors Denver, Colorado	$1.56M	+$499K	+179,300	+64%
47	47 Bank of Montreal Toronto, Ontario, Canada	$1.33M	+$2.78K	+1,000	+0.3%
48	MERSOM 48 Municipal Employees' Retirement System of Michigan Lansing, Michigan	$1.22M	+$1M	+361,020	New
49	CS 49 Credit Suisse Zurich, Switzerland	$1.22M	+$417K	+149,995	+72%
50	50 Wells Fargo San Francisco, California	$1.17M	+$28.5K	+10,239	+3%

PDLI Hedge Fund Activity: Q3 2017 in Review

186 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in PDL BioPharma, Inc. (PDLI) for Q3 2017, worth a combined $466M — up 45% from $321M a quarter earlier.

Buyers outnumbered sellers: 31 funds opened new PDLI positions and 13 closed out — a net gain of 18 holders — while 63 added to existing stakes and 44 trimmed.

The largest buyer was Millennium Management, adding an estimated $8.55M. The largest seller was Citadel Advisors, cutting an estimated $9.56M.

186 institutional investors held PDL BioPharma, Inc. (PDLI) as of Q3 2017, up from 171 in Q2 2017.
Funds reported $466M of PDL BioPharma, Inc. stock for Q3 2017, up 45% quarter-over-quarter.
31 funds opened new PDL BioPharma, Inc. positions in Q3 2017 and 13 closed out, a net change of +18 holders.
The largest PDL BioPharma, Inc. buyer in Q3 2017 was Millennium Management, an estimated $8.55M added.
The largest PDL BioPharma, Inc. seller in Q3 2017 was Citadel Advisors, an estimated $9.56M sold.

Based on aggregated 13F filings for Q3 2017.

PDL BioPharma, Inc. PDLI